KalVista Pharmaceuticals, Inc. (KALV)
16.85
+0.69
(+4.27%)
USD |
NASDAQ |
Dec 10, 16:00
16.85
0.00 (0.00%)
After-Hours: 16:59
KalVista Pharmaceuticals Total Liabilities (Quarterly): 322.93M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| BioCryst Pharmaceuticals, Inc. | 834.31M |
| Revolution Medicines, Inc. | 655.02M |
| Silvergate Capital Corp. | -- |
| Perspective Therapeutics, Inc. | 52.61M |
| Electromed, Inc. | 8.869M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 339.93M |
| Shareholders Equity (Quarterly) | 17.00M |
| Debt to Equity Ratio | 16.62 |
| Current Ratio | 7.216 |
| Net Debt Paydown Yield | -8.98% |